The presence of cold agglutinins (CAs) in samples intended for complete blood count (CBC) using automated haematology analysers might cause serious preanalytical errors. In this report we describe the case of a 90-year old female patient admitted to the Emergency department following trauma injuries. A blood testing on admission revealed surprisingly low red blood cell count (0.99 x 10 12 /L), low haematocrit (0.102 L/L) which did not correlate with haemoglobin concentration (100 g/L), and high erythrocytes indices (mean corpuscular haemoglobin, 101 pg; mean corpuscular haemoglobin concentration, 980 g/L). In the second sample, after repeated collection, almost equal results were observed. Blood smear examination under the microscope revealed clusters of erythrocytes. Cold agglutinins presence was suspected and, in order to get valid results, sample was warmed to 37 °C. Correction of CBC was observed. Furthermore, we performed some additional analysis to confirm the presence of CAs in this patient. The aim of this report was to present the laboratory findings in a case of CAs and propose a laboratory procedure for whole blood samples with suspected CAs.
Introduction
The advent of automated haematology analysers has resulted in high throughput and improved accuracy of complete blood count (CBC) results. However, various pre-analytical and analytical factors, as well as clinical conditions might affect the reliability of CBC results, including white blood cell count (WBC), red blood cell count (RBC) and RBC indices (MCV; mean corpuscular volume, MCH; mean corpuscular haemoglobin, MCHC; mean corpuscular haemoglobin concentration), and platelet count (Plt).
Cold agglutinins (CAs) are the most commonly immunoglobulin (Ig) M antibodies (rarely IgA or IgG) directed against polysaccharide antigens located on the surface of erythrocytes which become activated by low temperature. The resulting antigenantibody complex strongly activates the classical complement cascade, which might cause removal of RBCs in the reticuloendothelial system, intravascular and extravascular haemolysis (1) . Cold agglutinin disease (CAD) is a type of autoimmune haemolytic anaemia (AIHA) characterized by an immune reaction against RBC self-antigens. A cold exposure or a concurrent infection may be sufficient to trigger the clinical manifestation of disease (2) .
Cold agglutinins presence in samples intended for CBC analysis using automated haematology analysers might cause serious preanalytical errors. Most of the published reports on CAs presence are presented from a clinical perspective. Laboratory findings are usually scarce and the analytical perspective is often omitted. Several cases reported the importance of preanalytical effect of CAs on laboratory results, especially on CBC (3) (4) (5) . The aim of this report is to present the laboratory findings found in a case of CAs and propose a laboratory procedure for whole blood samples with suspected CAs.
Topic A. et al. A case report of cold agglutinins

Case report
A 90-year old female patient was admitted to the Emergency department (ED) of our hospital in December 2017 after trauma injuries. Following initial examination and due to nature of injuries, she was transferred to our dislocated traumatology unit where further diagnostic examinations were performed.
Laboratory analyses
As a part of diagnostic processing, samples were referred to our laboratory for routine haematology, coagulation, biochemistry, blood gas and urine analysis.
Peripheral blood for CBC, collected by venipuncture in 3.5 mL Vacuette ® tube (K 3 EDTA, Greiner BioOne, Kremsmunster, Austria), was analysed on Sysmex XT-1800i haematology analyser (Sysmex Corporation, Kobe, Japan). The results on admission are presented in Table 1 
Further investigations
To confirm the presence of CAs, we performed some additional analyses. Direct and indirect antiglobulin (Coombs) test using anti-IgG and anti-C3 antibodies were performed using MONOGnost ® monoclonal polyspecific anti-human globulin reagent (Biognost, Zagreb, Croatia) and the results were positive for direct and negative for indirect antiglobulin test. The results indicated in vivo sensitization of patient RBCs with IgG and/or C3 component of complement. Furthermore, the concentrations of IgG, IgA, IgM, C3 and C4 component of complement in patient's serum were determined on the Abbott Architect c8000 automated biochemistry analyser (Abbott Laboratories, IL, USA). Only concentration of IgM was above the upper reference limit which indicated that CAs in this case might be IgM class, such as usually found in CAD (Table 2) .
To prevent future analytical problems related to the presence of CAs in the patient's sample, we informed the clinical staff on the importance of immediate analysis of this patient's sample (i.e. immediate sample transport after collection was instituted for this sample alone). The results of haematology parameters determined during the rest of the patient's hospitalization period are presented in Table 3 . There were no further analytical problems when the sample was immediately transported to the laboratory. On the 3rd day of 
What happened?
Erroneous values of RBC count and RBC-dependent parameters in this case were the consequence of CAs presence in the patient's sample. Cold agglutinins led to RBC micro-aggregates formation, which resulted in inaccurately low RBC count. Consequently, errors were also detectable on Htc and RBC indices values. Interestingly, we later found out that the CBC was also performed on admission to the ED where unusual results were not observed. In fact, RBC was 3.3x10 12 
Solution
To solve preanalytical interference of CAs and get valid results, we warmed the sample at body temperature in order to achieve separation of agglutinated RBCs. To prevent future analytical problems, samples of this patient were delivered to the laboratory immediately after collection and promptly analysed. Considering organisation at our location, we can ensure the delivery of sample within 5 minutes of collection so the usual transport procedure at body temperature in water bath has not been applied.
A proposed laboratory procedure for whole blood samples with suspected CAs is presented in Figure  2 . Spuriously low RBC, Hct and elevated MCV, MCH and, especially MCHC, as well as discrepancy between Hct, Hb and RBC results should always trigger suspicion of CAs presence in blood samples. One of the most indicative parameters generated by haematology analysers is MCHC, because of its mode of calculation. Its abnormalities alarm the user that the sample has to be checked. A quick visual check of the Hb, Hct and RBC results can be done by applying the "Rules of Three". The rules say that the value of Hb should be aproximately three times the value of the RBC (RBC (10 12 /L) x 3 ~ Hb (g/dL)) and the value of Hct should be aproximately three times the value of the Hb (Hb (g/dL) x 3 ~ Hct (%)) (7). Although these rules apply only to specimens that have normocytic normochromic erythrocytes, they present a very simple and easy tool to detect possible samples with CAs within the large amount of routine samples. Effects of CAs are commonly visible on RBC count and RBCdependent parameters, but it is important to stress that effects can be also visible on Plt causing spuriously low Plt count and falsely increased mean platelet volume (MPV). Therefore, such results should also raise the suspicion on CAs presence in the blood sample. To confirm RBC or Plt agglutination in the sample, the best way is blood smear examination under the microscope. As shown in Figure 2 , the suspected presence of CAs has been raised, and the next step involves requesting a new sample and transporting that sample immediately after collection to the laboratory.
The tube for blood collection should be warmed and transported to the laboratory, without cooling, at 37 °C, in an insulated container filled with warmed water and in a styrofoam box. The analysis should be made as soon as the sample is received in the laboratory. After the presence of CAs is evidenced, on the test result report informative comment should be incorporated. The comment should contain information to the clinician about finding CAs in the patient sample and information how to draw every next sample from that patient. In case of inability to obtain a new sample, warming the suspicious sample may be an alternative, but such results should be carefully interpreted, because it is not possible to be sure that all RBCs are separated after sample warming. In case of reporting results informative comment should also (13) . Blood cell counts might also be affected at low temperature by cryoglobulins. Cryoglobulins are circulating immunoglobulins that become insoluble and precipitate in temperature between 4 °C and 37 °C causing analytical interference for automated blood cell counters, mainly resulting in pseudoleukocytosis and pseudothrombocytosis (14) (15) (16) . Passing through the aperture of the analyser, cryoglobulin particles might be counted as WBCs or Plt when they approximate their size, structure, and shape. Unlike CAs, cryoglobulins usually slightly affect RBC count and Hb measurement (14) . Therefore, CAs and cryoglobulins differentially interfere on blood cell counts, however laboratory procedure how to analyse such samples is the same in both cases.
What YOU should / can do in your laboratory to prevent such errors A proposed laboratory procedure to easily detect and prevent preanalytical errors caused by CAs presence in whole blood samples is presented in Figure 2 .
